Analysen zu Novo Nordisk
| 29.04.24 | Novo Nordisk Neutral | UBS AG | |
| 25.04.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 24.04.24 | Novo Nordisk Outperform | Bernstein Research | |
| 26.03.24 | Novo Nordisk Neutral | UBS AG | |
| 25.03.24 | Novo Nordisk Overweight | Barclays Capital | |
| 18.03.24 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.03.24 | Novo Nordisk Overweight | Barclays Capital | |
| 11.03.24 | Novo Nordisk Neutral | UBS AG | |
| 08.03.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 08.03.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 07.03.24 | Novo Nordisk Overweight | Barclays Capital | |
| 06.03.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 05.03.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.03.24 | Novo Nordisk Neutral | UBS AG | |
| 01.03.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 28.02.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 27.02.24 | Novo Nordisk Neutral | UBS AG | |
| 27.02.24 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.02.24 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.02.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 19.02.24 | Novo Nordisk Overweight | Barclays Capital | |
| 14.02.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 09.02.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 07.02.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 05.02.24 | Novo Nordisk Overweight | Barclays Capital | |
| 05.02.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.02.24 | Novo Nordisk Neutral | UBS AG | |
| 01.02.24 | Novo Nordisk Neutral | UBS AG | |
| 01.02.24 | Novo Nordisk Halten | DZ BANK | |
| 01.02.24 | Novo Nordisk Overweight | Barclays Capital | |
| 01.02.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 31.01.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 31.01.24 | Novo Nordisk Neutral | UBS AG | |
| 31.01.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 30.01.24 | Novo Nordisk Neutral | UBS AG | |
| 24.01.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 17.01.24 | Novo Nordisk Overweight | Barclays Capital | |
| 16.01.24 | Novo Nordisk Buy | Jefferies & Company Inc. | |
| 15.01.24 | Novo Nordisk Neutral | UBS AG | |
| 12.01.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 10.01.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 08.01.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.01.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 02.01.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 18.12.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 18.12.23 | Novo Nordisk Overweight | Barclays Capital | |
| 15.12.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 08.12.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 05.12.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 05.12.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. |
Aktuelle Aktienanalysen
| 11:16 | ProSiebenSat.1 Media Equal Weight | Barclays Capital | |
| 11:13 | KRONES Buy | Baader Bank | |
| 10:56 | PUMA Sector Perform | RBC Capital Markets | |
| 10:55 | adidas Outperform | RBC Capital Markets | |
| 10:47 | Fielmann Hold | Warburg Research | |
| 10:40 | Siemens Healthineers Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10:35 | Allianz Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10:21 | Air Liquide Buy | UBS AG | |
| 10:02 | KRONES Hold | Hauck Aufhäuser Lampe Privatbank AG | |
| 09:58 | Wolters Kluwer Neutral | UBS AG | |
| 09:55 | Novo Nordisk Neutral | UBS AG | |
| 08:37 | AB InBev Buy | UBS AG | |
| 08:34 | GSK Underweight | JP Morgan Chase & Co. | |
| 08:16 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 08:04 | PUMA Underweight | JP Morgan Chase & Co. | |
| 07:49 | Nike Outperform | RBC Capital Markets | |
| 17.09.25 | Kering Sector Perform | RBC Capital Markets | |
| 17.09.25 | Boeing Buy | Jefferies & Company Inc. | |
| 17.09.25 | Schaeffler Hold | Jefferies & Company Inc. | |
| 17.09.25 | Heidelberg Materials Outperform | RBC Capital Markets | |
| 17.09.25 | Volkswagen Sector Perform | RBC Capital Markets | |
| 17.09.25 | Schneider Electric Outperform | RBC Capital Markets | |
| 17.09.25 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.09.25 | Sanofi Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.09.25 | Pfizer Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.09.25 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.09.25 | GSK Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.09.25 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.09.25 | ProSiebenSat.1 Media Market-Perform | Bernstein Research | |
| 17.09.25 | thyssenkrupp Hold | Deutsche Bank AG | |
| 17.09.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 17.09.25 | Palfinger kaufen | Erste Group Bank | |
| 17.09.25 | UBM Development kaufen | Warburg Research | |
| 17.09.25 | Schaeffler Hold | Deutsche Bank AG | |
| 17.09.25 | Delivery Hero Overweight | JP Morgan Chase & Co. | |
| 17.09.25 | Prosus Overweight | JP Morgan Chase & Co. | |
| 17.09.25 | Schaeffler Neutral | UBS AG | |
| 17.09.25 | Givaudan Neutral | UBS AG | |
| 17.09.25 | Kontron kaufen | Erste Group Bank | |
| 17.09.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 17.09.25 | Inditex Buy | UBS AG | |
| 17.09.25 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 17.09.25 | Coca-Cola Outperform | RBC Capital Markets | |
| 17.09.25 | BAT Underperform | RBC Capital Markets | |
| 17.09.25 | Pernod Ricard Sector Perform | RBC Capital Markets | |
| 17.09.25 | Diageo Sector Perform | RBC Capital Markets | |
| 17.09.25 | AB InBev Outperform | RBC Capital Markets | |
| 17.09.25 | L'Oréal Outperform | RBC Capital Markets | |
| 17.09.25 | Reckitt Benckiser Outperform | RBC Capital Markets | |
| 17.09.25 | LPKF Laser & Electronics Buy | Warburg Research |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.